Impact of ARNI (angiotensin receptor neprilysin inhibitor) on functional status of patients with heart failure and reduced ejection fraction (HFREF)
ConclusionARNI was tolerated in 88% of patients when switched from ACEI/ARB and was associated with significant improvement in NYHA class in 68% of patients.
Source: Journal of the Saudi Heart Association - Category: Cardiology Source Type: research
More News: Beta-Blockers | Cardiology | Heart | Heart Failure | Middle East Health | Saudi Arabia Health | Urology & Nephrology